Selected article for: "acid detection and low throughput"
Author: Jennifer N Rauch; Eric Valois; Sabrina C Solley; Friederike Braig; Ryan S Lach; Naomi J Baxter; Kenneth S Kosik; Carolina Arias; Diego Acosta-Alvear; Maxwell Z Wilson
Title: A Scalable, Easy-to-Deploy, Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material
  • Document date: 2020_4_21
    • ID: hy1xrw6q_14
    Snippet: Current methods to detect SARS-CoV-2 presence or prior exposure in patient samples rely on detection of the viral genome or antibodies in nucleic acid and serological tests, respectively 24 . The detection of viral genome sequences by RT-qPCR is recommended by public health organizations worldwide. However, these recommendations fail to account for the massive need for widespread testing. Implementing this method alone places a single large burde.....
    Document: Current methods to detect SARS-CoV-2 presence or prior exposure in patient samples rely on detection of the viral genome or antibodies in nucleic acid and serological tests, respectively 24 . The detection of viral genome sequences by RT-qPCR is recommended by public health organizations worldwide. However, these recommendations fail to account for the massive need for widespread testing. Implementing this method alone places a single large burden on the manufacturing capacity for RT-qPCR testing reagents and consumables, specialized instrumentation, and trained laboratory personnel, thus hampering widespread testing. Other POC diagnostic platforms still require specialized instrumentation and are low throughput (e.g. Abbott ID NOW).

    Search related documents:
    Co phrase search for related documents
    • antibody viral genome and public health: 1
    • antibody viral genome and viral genome: 1, 2, 3, 4, 5, 6, 7
    • current method and diagnostic platform: 1
    • current method and genome sequence: 1
    • current method and laboratory personnel: 1
    • current method and low throughput: 1
    • current method and method implement: 1, 2
    • current method and patient sample: 1, 2, 3, 4
    • current method and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • current method and public health organization: 1
    • current method and SARS presence: 1, 2, 3, 4
    • current method and serological test: 1
    • current method and viral genome: 1, 2, 3, 4, 5, 6, 7, 8
    • current method and viral genome sequence: 1, 2
    • current method and widespread testing: 1
    • diagnostic platform and laboratory personnel: 1, 2
    • diagnostic platform and low throughput: 1, 2
    • diagnostic platform and patient sample: 1, 2, 3
    • diagnostic platform and POC diagnostic platform: 1, 2, 3, 4, 5, 6